February 01, 2005 Lehigh Valley, Pa.
Margaret G. McGlynn, President, U.S. Human Health for Merck & Co., Inc., has been elected to Air Products' (NYSE:APD) board of directors.
Air Products' Chairman and Chief Executive Officer John P. Jones said, "Margie brings extensive healthcare leadership and industry experience to our board, which will be tremendously valuable as we continue to expand our global healthcare business serving both homecare patients and medical institutions."
McGlynn, 45, joined Merck in 1983 as a professional representative and has spent the past 22 years with the company in positions of increasing responsibility, including marketing, sales, managed care and business development. She has held a number of senior-level positions, including Senior Vice President, Managed Care and Senior Vice President, Worldwide Human Health Marketing at Merck, as well as Senior Vice President, Health and Utilization Management, at Merck-Medco. More recently, she was Executive Vice President, Customer Marketing and Sales, before assuming her current role.
As President, U.S. Human Health, McGlynn has U.S. responsibility for Merck's specialty and infectious disease medicines, managed care marketing and sales for Merck's full product line, and marketing planning for drugs in late-stage development. She is a member of Merck's Management Committee, which is responsible for formulating global business strategies, operations management and the development and implementation of corporate policies.
McGlynn holds a Master of Business Administration and a bachelor's degree in pharmacy, both from the State University of New York at Buffalo. She previously served on the boards of Quidel Corporation and Amphion Capital Partners, LLC, and she currently serves on the board of the New Jersey Performing Arts Center and the Corporate Executive Board of the Philadelphia Museum of Art.
Air Products (NYSE:APD) serves customers in technology, energy, healthcare and industrial markets worldwide with a unique portfolio of products, services and solutions, providing atmospheric gases, process and specialty gases, performance materials and chemical intermediates. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of $7.4 billion, operations in over 30 countries, and nearly 20,000 employees around the globe. For more information, visit www.airproducts.com.
NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.